World's Best Scientists 2026 revealed!
Nicolino Ruperto

Nicolino Ruperto

D-Index & Metrics

Medicine

D-Index
96
Citations
37035
World Ranking
9595
National Ranking
332

Nicolino Ruperto publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Nicolino Ruperto sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 438 publications — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Nicolino Ruperto D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Nicolino Ruperto sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 96 D-Index — 53rd percentile

53% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Nicolino Ruperto is affiliated with the Istituto Giannina Gaslini in Italy and has contributed extensively to the field of medicine, particularly in hematology, rheumatology, and molecular biology. Their research primarily focuses on autoimmune and inflammatory disorders, adolescent and pediatric healthcare, as well as specific conditions such as Kawasaki disease and systemic lupus erythematosus.

Their recent notable publications include:

  • "Juvenile idiopathic arthritis," 2022, published in Nature Reviews Disease Primers
  • "Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial," 2020, published in Annals of the Rheumatic Diseases
  • "The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist," 2022, published in Annals of the Rheumatic Diseases
  • "Biological classification of childhood arthritis: roadmap to a molecular nomenclature," 2021, published in Nature Reviews Rheumatology
  • "Definition and Validation of the American College of Rheumatology 2021 Juvenile Arthritis Disease Activity Score Cutoffs for Disease Activity States in Juvenile Idiopathic Arthritis," 2021, published in Arthritis & Rheumatology

Frequent coauthors collaborating with Nicolino Ruperto include:

  • Hermine I. Brunner
  • Alberto Martini
  • Daniel J. Lovell
  • Jordi Antón
  • Marco Gattorno

The scientist has published predominantly in journals such as:

  • Annals of the Rheumatic Diseases
  • Lara D. Veeken
  • Arthritis & Rheumatology
  • Arthritis Care & Research
  • The Journal of Rheumatology

The main fields of study for this researcher are concentrated in medicine, with particular focus on:

  • Hematology
  • Speech and Hearing
  • Rheumatology
  • Surgery
  • Molecular Biology

Key research topics covered in their work include:

  • Autoimmune and Inflammatory Disorders Research
  • Adolescent and Pediatric Healthcare
  • Kawasaki Disease and Coronary Complications
  • Inflammasome and immune disorders
  • Rheumatoid Arthritis Research and Therapies
  • Systemic Lupus Erythematosus Research
  • Acute Lymphoblastic Leukemia research

Best Publications

  • EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria.

    Seza Ozen;Angela Pistorio;Silvia M. Iusan;Aysin Bakkaloglu

  • Preliminary definition of improvement in juvenile arthritis

    Edward H. Giannini;Nicolino Ruperto;Angelo Ravelli;Daniel J. Lovell

  • EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides

    Seza Ozen;Nicolino Ruperto;Michael Dillon;Arvind Bagga

  • 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Initiation and Safety Monitoring of Therapeutic Agents for the Treatment of Arthritis and Systemic Features

    Timothy Beukelman;Nivedita M. Patkar;Kenneth G. Saag;Sue Tolleson-Rinehart

  • Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis.

    Fabrizio De Benedetti;Hermine I. Brunner;Nicolino Ruperto;Andrew Kenwright

  • Development and validation of a composite disease activity score for juvenile idiopathic arthritis.

    Alessandro Consolaro;Nicolino Ruperto;Anna Bazso;Angela Pistorio

  • Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis

    Nicolino Ruperto;Hermine I. Brunner;Pierre Quartier;Tamás Constantin

  • Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis

    Daniel J. Lovell;Nicolino Ruperto;Steven Goodman;Andreas Reiff

  • 2016 Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: A European league against Rheumatism/American college of Rheumatology/Paediatric rheumatology international trials organisation collaborative initiative

    Angelo Ravelli;Francesca Serena Minoia;Sergio Davi;Anna Carin Horne

  • Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis

    Carol A Wallace;Nicolino Ruperto;Edward Giannini

  • Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial

    Nicolino Ruperto;Daniel J Lovell;Pierre Quartier;Eliana Paz

  • Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.

    Angelo Ravelli;Silvia Magni-Manzoni;Angela Pistorio;Cristina Besana

  • American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis

    Carol A. Wallace;Edward H. Giannini;Bin Huang;Lukasz Itert

  • A randomized, placebo‐controlled trial of infliximab plus methotrexate for the treatment of polyarticular‐course juvenile rheumatoid arthritis

    Nicolino Ruperto;Daniel J. Lovell;Ruben Cuttica;Nick Wilkinson

  • Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review

    Nienke Ter Haar;Helen Lachmann;Seza Özen;Pat Woo

  • A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate.

    Nicolino Ruperto;Kevin J. Murray;Valeria Gerloni;Nico Wulffraat

  • Cross-cultural adaptation and psychometric evaluation of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ) in 32 countries. Review of the general methodology

    N Ruperto;A Ravelli;A Pistorio;C Malattia

  • Toward New Classification Criteria for Juvenile Idiopathic Arthritis : First Steps, Pediatric Rheumatology International Trials Organization International Consensus

    Alberto Martini;Angelo Ravelli;Tadej Avcin;Michael W. Beresford

  • Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients.

    Francesca Minoia;Sergio Davì;Annacarin Horne;Erkan Demirkaya

  • 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis

    Angelo Ravelli;Francesca Minoia;Sergio Davì;Annacarin Horne

Frequent Co-Authors

Alberto Martini
Alberto Martini University of Genoa
Angelo Ravelli
Angelo Ravelli University of Genoa
Angela Pistorio
Angela Pistorio Istituto Giannina Gaslini
Daniel J. Lovell
Daniel J. Lovell Cincinnati Children's Hospital Medical Center
Nico M Wulffraat
Nico M Wulffraat Utrecht University
Marco Gattorno
Marco Gattorno Istituto Giannina Gaslini
Fabrizio De Benedetti
Fabrizio De Benedetti Bambino Gesù Children's Hospital
Rolando Cimaz
Rolando Cimaz University of Milan
Seza Ozen
Seza Ozen Hacettepe University
Edward H. Giannini
Edward H. Giannini Cincinnati Children's Hospital Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative healthcare degrees can open rewarding career opportunities beyond the traditional medical school route. One popular pathway for those with a non-nursing background is enrolling in direct entry msn programs for non-nursing majors. These accelerated tracks enable students to quickly transition into advanced nursing roles.

If you’re looking for flexibility or balancing multiple commitments, nursing education offers accessible options. Many aspiring nurses seek out the easiest rn program as a way to fast-track their entry into the workforce. Additionally, some schools offer an lpn program without teas test—eliminating common hurdles and making the admissions process more approachable.

Not all healthcare careers require direct patient care. For those interested in the administrative side, online medical coding classes with financial aid can provide a fast entry into the growing field of medical billing and coding.

Each of these online degrees and pathways offers a unique approach to entering the healthcare sector, with options to fit a range of educational backgrounds and career interests.

Best Scientists Citing Nicolino Ruperto

Trending Scientists

Recently Published Articles